Analyzing tumor microenvironment at single cell level sheds light on metastatic melanoma outcomes

TAMPA, Fla. — There are several new treatment options available for patients with advanced melanoma. While these therapies have greatly improved the prognosis for patients, each person can respond to the treatments differently. Treatment of melanomas that have spread to the central nervous system is especially challenging. In a new article published in Clinical Cancer…

Details

Curis, Inc. announces ‘VISTA: A new immune checkpoint in cancer, autoimmunity and beyond’

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced the virtual symposium, “VISTA: A New Immune Checkpoint in Cancer, Autoimmunity and Beyond,” taking place on June 18, 2021, 9:00-1:15 PM ET. Leaders in immunology across industry and academia will gather to discuss emerging…

Details

Obrusnikova honored

Iva Obrusnikova, an associate professor in the Department of Behavioral Health and Nutrition, has been selected as a Fellow with the International Federation of Adapted Physical Activity (IFAPA). The IFAPA Fellows Recognition Program recognizes and promotes outstanding accomplishments in scholarship and service by IFAPA members. Fellow status is awarded to IFAPA members who have made…

Details

Athletic competition after COVID

MEMPHIS, Tenn. – Cardiovascular imaging demonstrated no evidence of myocardial injury or myocarditis in athletes after COVID-19 infection, according to a research letter published in Circulation by Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center cardiologists. The screening and evaluation was conducted by the Le Bonheur Children’s Heart Institute Sports Cardiology…

Details

The dream team: Scientists find drug duo that may cure COVID-19 together

COVID-19 continues to claim lives across the world and is infecting millions more. Although several vaccines have recently become available, making significant strides towards preventing COVID-19, what about the treatment of those who already have the infection? Vaccines aren’t 100% effective, highlighting the need–now more than ever–for effective antiviral therapeutics. Moreover, some people can’t receive…

Details

Notre Dame experiment is en route to the space station; could lead to more effective early cancer screenings

Researchers studying how bubbles form and function sent a fully automated, self-contained experiment to the International Space Station (ISS) aboard a Space X rocket that launched this afternoon. The study, led by Tengfei Luo, a professor in the Department of Aerospace and Mechanical Engineering at the University of Notre Dame, will be initiated by astronauts…

Details

Immunotherapy after bladder cancer surgery may reduce recurrence, study shows

NEW YORK CITY, June 2, 2021 — New research from Memorial Sloan Kettering Cancer Center (MSK) medical oncologist Dean Bajorin, MD, and colleagues found that patients who received nivolumab (Opdivo®) after bladder cancer surgery reduced their overall risk for high-grade bladder cancer recurrence. This research was published in the New England Journal of Medicine. In…

Details